pyrroles has been researched along with dihydropyridines in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.85) | 18.7374 |
| 1990's | 17 (65.38) | 18.2507 |
| 2000's | 3 (11.54) | 29.6817 |
| 2010's | 5 (19.23) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armstrong, JM; Barras, M; Hicks, PE; Lawson, K; Martin, DJ; Zazzi-Sudriez, E | 1 |
| Lacerda, AE; Rampe, D | 1 |
| Bertrand, JP; Gautier, P; Guiraudou, P | 1 |
| Rampe, D; Triggle, DJ; Zheng, W | 1 |
| Haeusler, G | 1 |
| Franke, C; Hatt, H; Quasthoff, S; Richter-Turtur, M | 1 |
| Kaneko, K; Miyata, N; Otomo, S; Tanaka, M; Tsuchida, K | 1 |
| Grafe, P; Lehmann-Horn, F; Quasthoff, S; Spittelmeister, W; Spuler, A | 1 |
| Doussau, MP; Gautier, P; Giudicelli, JF; Mulder, P; Richer, C | 1 |
| Doussau, MP; Giudicelli, JF; Mulder, P; Richer, C | 1 |
| Dockrell, ME; Haynes, WG; Olverman, HJ; Waugh, CJ; Webb, DJ; Williams, BC | 1 |
| Parsons, AA; Schilling, L; Wahl, M | 1 |
| Grover, GJ | 1 |
| Cavero, I; Premmereur, J | 1 |
| Adams, ME; Mori, Y; Sather, WA; Tanabe, T; Tsien, RW; Zhang, JF | 1 |
| Glossmann, H; Grabner, M; Hering, S; Striessnig, J; Wang, Z | 1 |
| Alaiz, M; Hidalgo, FJ; Zamora, R | 1 |
| Drew, T; Jinnah, HA; Kim, BS; Rothstein, JD; Visser, JE; Yitta, S | 1 |
| Gullapalli, S; Ramarao, P | 1 |
| Adachi-Akahane, S; Ichijo, H; Nagao, T; Yamaguchi, S; Yoshioka, K; Zhorov, BS | 1 |
| Beier, N; El Schultz, J; Gross, GJ; Gumina, RJ; Moore, J; Schelling, P | 1 |
| Cinalli, AR; Fernandez, V; Guarracino, JF; Losavio, AS; Roquel, LI | 1 |
| Fadda, AA; Refat, HM | 1 |
| Brown, I; Gallivan, C | 1 |
| Menon, RS; Nanubolu, JB; Singarapu, KK; Thadkapally, S; Undeela, S | 1 |
| Álvarez de la Rosa, D; Gerona-Navarro, G; González-Muñiz, R; Martín-Martínez, M; Pérez-Gordillo, FL; Rodríguez, Y; Zhou, MM | 1 |
2 review(s) available for pyrroles and dihydropyridines
| Article | Year |
|---|---|
K(+)-channel openers: new antihypertensive drugs?
Topics: Antihypertensive Agents; Benzopyrans; Cromakalim; Dihydropyridines; Guanidines; Hemodynamics; Humans; Hypertension; Molecular Structure; Pinacidil; Potassium Channels; Pyrroles | 1990 |
Protective effects of ATP-sensitive potassium-channel openers in experimental myocardial ischemia.
Topics: Action Potentials; Adenosine Triphosphate; Animals; Benzopyrans; Cromakalim; Dihydropyridines; Disease Models, Animal; Dogs; Guanidines; Guinea Pigs; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Picolines; Pinacidil; Potassium Channels; Pyrans; Pyrroles; Rats; Vasodilator Agents | 1994 |
24 other study(ies) available for pyrroles and dihydropyridines
| Article | Year |
|---|---|
Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
Topics: Animals; Aorta; Benzopyrans; Cromakalim; Cyclopentanes; Dihydropyridines; Dose-Response Relationship, Drug; Endothelins; Guanidines; Hypertension; In Vitro Techniques; Male; Muscle Relaxation; Muscle, Smooth, Vascular; Pinacidil; Potassium Channels; Pyridines; Pyrroles; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Vasodilation; Vasodilator Agents | 1992 |
A new site for the activation of cardiac calcium channels defined by the nondihydropyridine FPL 64176.
Topics: Animals; Barium; Calcium; Calcium Channel Blockers; Calcium Channels; Cells, Cultured; Dihydropyridines; Electrophysiology; Heart; Heart Ventricles; Isradipine; Myocardium; Potassium; Pyrroles; Rats; Ventricular Function | 1991 |
Effects of SR 44866, a potassium channel opener, on action potentials of rabbit, guinea pig, and human heart fibers.
Topics: Action Potentials; Animals; Benzopyrans; Cromakalim; Dihydropyridines; Electrophysiology; Guinea Pigs; Heart; Heart Atria; Humans; Male; Muscle, Smooth, Vascular; Myocardial Contraction; Papillary Muscles; Potassium Channels; Purkinje Fibers; Pyrroles; Rabbits; Vasodilator Agents | 1991 |
Pharmacological, radioligand binding, and electrophysiological characteristics of FPL 64176, a novel nondihydropyridine Ca2+ channel activator, in cardiac and vascular preparations.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Diltiazem; Dose-Response Relationship, Drug; Heart; In Vitro Techniques; Isradipine; Male; Myocardium; Potassium; Pyrroles; Radioligand Assay; Rats; Vasoconstriction; Verapamil | 1991 |
Two different types of potassium channels in human skeletal muscle activated by potassium channel openers.
Topics: Adenosine Triphosphate; Benzopyrans; Cromakalim; Dihydropyridines; Electrophysiology; Glyburide; Humans; Muscles; Picolines; Potassium Channels; Pyrans; Pyrroles | 1990 |
Mechanisms of inhibitory effects of CD-349 and K(+)-channel activators on noradrenaline-induced contraction and changes in levels of cyclic GMP in rat aorta.
Topics: Animals; Aorta, Thoracic; Benzopyrans; Calcium Channel Agonists; Calcium Channel Blockers; Cromakalim; Cyclic GMP; Dihydropyridines; Glyburide; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Potassium Channels; Pyrroles; Rats; Rats, Inbred Strains | 1990 |
K+ channel openers suppress myotonic activity of human skeletal muscle in vitro.
Topics: Benzopyrans; Cell Membrane Permeability; Cromakalim; Dihydropyridines; Humans; In Vitro Techniques; Microelectrodes; Muscle Contraction; Muscles; Potassium Channels; Pyrroles; Vasodilator Agents | 1990 |
Systemic and regional haemodynamic interactions between K+ channel openers and the sympathetic nervous system in the pithed SHR.
Topics: Animals; Benzopyrans; Brimonidine Tartrate; Cromakalim; Decerebrate State; Dihydropyridines; Heart Rate; Hemodynamics; Imidazoles; Male; Potassium Channels; Pyrroles; Quinoxalines; Rats; Rats, Inbred SHR; Regional Blood Flow; Sympathetic Nervous System; Vascular Resistance | 1990 |
[Potassium agonists: regional vasodilator profile in rats].
Topics: Animals; Benzopyrans; Cromakalim; Dihydropyridines; Hemodynamics; Male; Nicardipine; Pyrroles; Rats; Rats, Inbred Strains; Vasodilator Agents | 1989 |
Modulators of calcium and potassium channels: their effects on endothelin-1 binding to cardiac membranes.
Topics: Animals; Benzopyrans; Calcium Channels; Cromakalim; Dihydropyridines; Endothelins; Heart; In Vitro Techniques; Male; Membranes; Myocardium; Nifedipine; Potassium Channels; Pyrroles; Rats; Rats, Sprague-Dawley | 1993 |
Effects of potassium channel activators on isolated cerebral arteries of large and small diameter in the cat.
Topics: Animals; Benzopyrans; Cats; Cerebral Arteries; Cromakalim; Dihydropyridines; Dose-Response Relationship, Drug; Female; Glyburide; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Potassium Channels; Pyrroles; Uridine Triphosphate; Vasodilator Agents | 1995 |
ATP sensitive potassium channel openers are of potential benefit in ischaemic heart disease.
Topics: Benzopyrans; Cromakalim; Dihydropyridines; Guanidines; Humans; Myocardial Ischemia; Myocardium; Niacinamide; Nicorandil; Picolines; Pinacidil; Potassium Channels; Pyrans; Pyrroles; Sodium-Potassium-Exchanging ATPase; Vasodilator Agents | 1994 |
Distinctive biophysical and pharmacological properties of class A (BI) calcium channel alpha 1 subunits.
Topics: Animals; Biophysical Phenomena; Biophysics; Cadmium; Calcium Channel Blockers; Calcium Channels; Dihydropyridines; Electrophysiology; Kinetics; Mollusk Venoms; omega-Conotoxins; Peptides; Pyrroles; Spider Venoms | 1993 |
Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels.
Topics: Amino Acid Sequence; Animals; Binding Sites; Calcium; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Carps; Dihydropyridines; Ion Channel Gating; Isradipine; Molecular Sequence Data; omega-Agatoxin IVA; omega-Conotoxins; Peptide Fragments; Peptides; Protein Structure, Tertiary; Pyrroles; Rabbits; Recombinant Fusion Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Spider Venoms | 1996 |
Feed-back inhibition of oxidative stress by oxidized lipid/amino acid reaction products.
Topics: Alanine; Aldehydes; Amino Acids; Animals; Antioxidants; Ascorbic Acid; Butylated Hydroxytoluene; Copper; Dihydropyridines; Feedback; Ferric Compounds; Free Radical Scavengers; Hydrogen Peroxide; Microsomes; Molecular Structure; Muscles; Oncorhynchus mykiss; Oxidative Stress; Pyrroles; Reactive Oxygen Species; Thiobarbituric Acid Reactive Substances | 1997 |
Calcium channel activation and self-biting in mice.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Aggression; Animals; Behavior, Animal; Bites and Stings; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Diltiazem; Ion Channel Gating; Mice; Mice, Inbred C57BL; Nifedipine; Nimodipine; Nitrendipine; Pyrroles; Self-Injurious Behavior | 1999 |
L-type Ca2+ channel modulation by dihydropyridines potentiates kappa-opioid receptor agonist induced acute analgesia and inhibits development of tolerance in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesia; Animals; Benzeneacetamides; Calcium Channels, L-Type; Cannabinoids; Dihydropyridines; Dose-Response Relationship, Drug; Drug Synergism; Drug Tolerance; Male; Pyrroles; Pyrrolidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Thiophenes | 2002 |
Key roles of Phe1112 and Ser1115 in the pore-forming IIIS5-S6 linker of L-type Ca2+ channel alpha1C subunit (CaV 1.2) in binding of dihydropyridines and action of Ca2+ channel agonists.
Topics: Alanine; Animals; Calcium Channel Agonists; Calcium Channel Blockers; Calcium Channels, L-Type; Dihydropyridines; Isradipine; Phenylalanine; Point Mutation; Protein Subunits; Pyrroles; Rats; Repetitive Sequences, Nucleic Acid; Serine | 2003 |
Cardioprotective-mimetics reduce myocardial infarct size in animals resistant to ischemic preconditioning.
Topics: Animals; Benzamides; Benzopyrans; Cardiotonic Agents; Dihydropyridines; Disease Models, Animal; Dogs; Heart; Ischemic Preconditioning, Myocardial; Myocardial Infarction; Potassium Channels; Pyrroles; Reperfusion Injury; Sodium-Hydrogen Exchangers; Time Factors | 2005 |
Inosine induces presynaptic inhibition of acetylcholine release by activation of A3 adenosine receptors at the mouse neuromuscular junction.
Topics: Acetylcholine; Animals; Calcium Channel Blockers; Carbazoles; Diaphragm; Dihydropyridines; Ethylmaleimide; Female; Inosine; Male; Mice; Neuromuscular Junction; Phrenic Nerve; Pyrroles; Receptor, Adenosine A3; Receptors, Purinergic P1 | 2013 |
Synthesis and antimicrobial activity of some novel hydrazide, benzochromenone, dihydropyridine, pyrrole, thiazole and thiophene derivatives.
Topics: Anti-Bacterial Agents; Antifungal Agents; Benzopyrans; Candida albicans; Dihydropyridines; Dose-Response Relationship, Drug; Escherichia coli; Hydrazones; Microbial Sensitivity Tests; Molecular Structure; Pyrroles; Staphylococcus aureus; Structure-Activity Relationship; Thiazoles; Thiophenes | 2013 |
Olmesartan induced enterocolitis.
Topics: Aged; Amitriptyline; Anticholesteremic Agents; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Atenolol; Atorvastatin; Dihydropyridines; Enterocolitis; Female; Heptanoic Acids; Humans; Imidazoles; Pyrroles; Tetrazoles | 2014 |
Catalyst-controlled divergence in cycloisomerisation reactions of N-propargyl-N-vinyl sulfonamides: gold-catalysed synthesis of 2-sulfonylmethyl pyrroles and dihydropyridines.
Topics: Catalysis; Cyclization; Dihydropyridines; Gold; Isomerism; Pyrroles; Sulfonamides; Sulfones | 2015 |
Modulating Mineralocorticoid Receptor with Non-steroidal Antagonists. New Opportunities for the Development of Potent and Selective Ligands without Off-Target Side Effects.
Topics: Amino Acid Sequence; Animals; Benzoxazines; Dihydropyridines; Drug Discovery; Humans; Ligands; Macrolides; Mineralocorticoid Receptor Antagonists; Models, Molecular; Oxazolidinones; Peptides; Pyrazoles; Pyrroles; Receptors, Mineralocorticoid; Structure-Activity Relationship; Sulfonamides | 2017 |